Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Short Interest Up 703.2% in April

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) was the target of a significant increase in short interest during the month of April. As of April 30th, there was short interest totaling 842,591 shares, an increase of 703.2% from the April 15th total of 104,904 shares. Based on an average daily volume of 2,374,575 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.0% of the company’s shares are short sold.

Reckitt Benckiser Group Trading Up 0.2%

Shares of RBGLY traded up $0.03 during mid-day trading on Tuesday, hitting $12.47. The company’s stock had a trading volume of 405,932 shares, compared to its average volume of 643,666. The company’s 50-day moving average is $13.96 and its 200-day moving average is $15.44. Reckitt Benckiser Group has a 52-week low of $12.40 and a 52-week high of $17.80. The company has a debt-to-equity ratio of 0.98, a current ratio of 0.85 and a quick ratio of 0.63.

Analysts Set New Price Targets

Several equities research analysts have issued reports on RBGLY shares. Zacks Research cut shares of Reckitt Benckiser Group from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Kepler Capital Markets raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 17th. Citigroup assumed coverage on Reckitt Benckiser Group in a research note on Wednesday, January 14th. They issued a “buy” rating on the stock. Royal Bank Of Canada downgraded Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a report on Wednesday, January 14th. Finally, Morgan Stanley upgraded Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a report on Monday, March 16th. Three investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Reckitt Benckiser Group presently has a consensus rating of “Moderate Buy”.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.